Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 2/2015

01-04-2015

Cushing disease: Where do we stand, where are we heading?

Authors: Maria Fleseriu, Stephan Petersenn

Published in: Pituitary | Issue 2/2015

Login to get access

Excerpt

Cushing disease is a fascinating disorder, one which poses a great clinical challenge to endocrinologists. Both the screening and confirmatory diagnosis are hindered by overlapping clinical features and biochemical test results in patients with Cushing’s syndrome and other more common morbidities, such as obesity and depression. The search for an underlying pituitary tumor can often be difficult, as an adrenocorticotropic hormone (ACTH)-secreting adenoma may be barely visible on magnetic resonance (MR) imaging, and differential diagnosis of an ectopic ACTH-secreting tumor may require invasive procedures. …
Metadata
Title
Cushing disease: Where do we stand, where are we heading?
Authors
Maria Fleseriu
Stephan Petersenn
Publication date
01-04-2015
Publisher
Springer US
Published in
Pituitary / Issue 2/2015
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-015-0647-4

Other articles of this Issue 2/2015

Pituitary 2/2015 Go to the issue

ReviewPaper

Current status on histological classification in Cushing’s disease

ReviewPaper

Medical combination therapies in Cushing’s disease

ReviewPaper

Comorbidities in Cushing’s disease

ReviewPaper

Update on radiation therapy in patients with Cushing’s disease

ReviewPaper

Approach to the postoperative patient with Cushing’s disease

ReviewPaper

Bilateral adrenalectomy for Cushing’s disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits